logo-loader

LexaGene hires two salespeople to tackle diagnostic and vet market with new MiQLab analyzers

Published: 09:06 14 Jul 2020 EDT

LexaGene (CVE: LXG-OTCQB: LXXGF) CEO Dr Jack Regan joined Steve Darling from Proactive Vancouver with news the company has made two key sales hires as they look to begin to roll out their genetic analyzers for rapid pathogen detection called MiQLab.

Regan says they are hiring in the diagnostic and veterinarian space which will be two very key markets for the company. Regan also told Proactive they have exercised 99% of their warrants and brought in a large amount of cash for the treasury.

Xeris Biopharma Surpasses 2023 Expectations with Strategic Moves Poised for...

Xeris Biopharma CEO Paul Edick joined Steve Darling from Proactive to share news the company had a successful 2023, with a final tally of 164 million USD, which is at the upper end of their forecast. The company concluded the year with 72 million USD in cash, surpassing their initial projections...

8 hours, 53 minutes ago